Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2032Including: 1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis3) By End-User: Hospitals And Diagnostic Laboratories; Physicians Office Laboratories; Reference Laboratories; Academics And Research FacilitiesCovering: Beckton, Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation (Cepheid Inc.)
Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035Including: 1) By End-User: Pharmaceuticals; Academic Research; Medical Devices; Chemicals & Pesticides; CosmeticsCovering: Cyprotex; Bio-Rad Laboratories, Inc; BioIVT; Emulate, Inc; MatTek Corporation
Global Tuberculosis (TB) Diagnostics Market Size study & Forecast, by Diagnostics Test Type (Radiographic Test, Laboratory Test, Nucleic Acid Testing, Cytokine Detection Test, Other Diagnostic Test Types), by End-User (Hospitals/ Clinics, Diagnostics/ Research Laboratory, Other End-Users), and Regional Analysis, 2022-2029
Global Central Nervous System Biomarkers Market Size study & Forecast, by Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Others) by Application (Drug Discovery and Development, Personalized Medicine, Other Applications), by End User (Diagnostic Labs, Clinics/Hospitals, Research Centers) and Regional Analysis, 2022-2029
The global humanized mouse and rat model market is projected to reach USD 338 million by 2027 from USD 237 million in 2022, at a CAGR of 7.4% during the forecast period of 2022 to 2027. Currently, immunodeficient mice engrafted with functional human cells…
Global Companion Diagnostics Market Size study & Forecast, by Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing and Other Technologies) by Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma and Other Indications), By End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, CROs and Others)and Regional Analysis, 2022-2029
Multiplex Assays Market by Product & Service (Consumables, Instruments, Software & Services), Type (Nucleic Acid, Protein), Technology (Flow Cytometry, Luminescence), Application (R&D, Diagnosis), End User (Pharma, Hospitals) - Global Forecast to 2027
In the UAE, with the rising consciousness about appearance among the younger generation, product improvements in anti-ageing, growing beauty, and the personal care sector, owing to increasing concerns about reducing age-related skin imperfections and impr…
Global Multicancer Screening Market Industry Overview
The global multicancer screening market is projected to reach $7.78 billion by 2032 from $1.90 billion in 2022, growing at a CAGR of 15.09% during the forecast period 2023-2032. The growth in the glob…
Global Cell-Based Assay Market Industry Overview
The global cell-based assay market is expected to reach $38.23 billion in 2032 from $17.20 billion in 2022, at a CAGR of 8.44% during the forecast period 2023-2032.
Market Lifecycle Stage
The global cell…
Healthcare Cybersecurity Market by Offering (Solutions and Services), Solution Type, Threat Type, Security Type, End Use Industry (Hospitals and Healthcare Facilities, Medical Device Manufacturers) and Region - Global Forecast to 2028